Eliot Bourk
Corporate Officer/Principal presso CHIMERIC THERAPEUTICS LIMITED
Patrimonio netto: 82 412 $ in data 30/04/2024
Profilo
Eliot Bourk is currently the Chief Business Officer & Head-External Innovation at Chimeric Therapeutics Ltd.
(Australia).
Previously, he worked at Celgene Corp.
as a Member.
He holds a doctorate degree from the University of California.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2023 | 4 230 603 ( 0.50% ) | 82 412 $ | 30/04/2024 |
Posizioni attive di Eliot Bourk
| Società | Posizione | Inizio |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 23/02/2021 |
Precedenti posizioni note di Eliot Bourk
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Formazione di Eliot Bourk
| University of California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Eliot Bourk
